Gabriel Mesquita Zangirolani

ORCID：0009-0005-7081-0185

发表论文 39 篇 · 总被引 5 次 · h-index 2

代表论文

• Figure 2 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
• Supplementary Figure S8 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
• Supplementary Data 3 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
• Supplementary Data 5 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
• Supplementary Figure S14 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)
• Supplementary Figure S16 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types (2026)